Gutiérrez-Cáceres, C.; Ávila, N.; Cerpa, L.C.; Martínez, M.F.; Irarrazabal, C.E.; Torres, B.; Barajas, O.; Varela, N.M.; Quiñones, L.A.
Association of OPRM1 and OPRD1 Polymorphisms with Pain and Opioid Adverse Reactions in Colorectal Cancer. Pharmaceuticals 2025, 18, 220.
https://doi.org/10.3390/ph18020220
AMA Style
Gutiérrez-Cáceres C, Ávila N, Cerpa LC, Martínez MF, Irarrazabal CE, Torres B, Barajas O, Varela NM, Quiñones LA.
Association of OPRM1 and OPRD1 Polymorphisms with Pain and Opioid Adverse Reactions in Colorectal Cancer. Pharmaceuticals. 2025; 18(2):220.
https://doi.org/10.3390/ph18020220
Chicago/Turabian Style
Gutiérrez-Cáceres, Carolina, Nikolas Ávila, Leslie C. Cerpa, Matías F. Martínez, Carlos E. Irarrazabal, Benjamín Torres, Olga Barajas, Nelson M. Varela, and Luis A. Quiñones.
2025. "Association of OPRM1 and OPRD1 Polymorphisms with Pain and Opioid Adverse Reactions in Colorectal Cancer" Pharmaceuticals 18, no. 2: 220.
https://doi.org/10.3390/ph18020220
APA Style
Gutiérrez-Cáceres, C., Ávila, N., Cerpa, L. C., Martínez, M. F., Irarrazabal, C. E., Torres, B., Barajas, O., Varela, N. M., & Quiñones, L. A.
(2025). Association of OPRM1 and OPRD1 Polymorphisms with Pain and Opioid Adverse Reactions in Colorectal Cancer. Pharmaceuticals, 18(2), 220.
https://doi.org/10.3390/ph18020220
